Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via nf-κb activation

HIGHLIGHTS

• who: Jia Xia from the Tissue collection and ethical approval A total of , pathological tissues from patients with prostate cancer or benign prostate hyperplasia were collected at Xiangya Hospital (Changsha, China) from Jan , to Jan All postoperative pathological tissue from patients were confirmed PCa or BPH as defined by a trained pathologist. Our study was approved by the Ethics Committee of Xiangya School of Medicine, Central South University (Registration number: #202012234). Written informed consents were obtained from all patients. have published the research: Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.